Patients with a history or family history of thyroid cancer, or with multiple endocrine neoplasia syndrome Type 2 (MEN 2) should not take Ozempic or Victoza
Researchers from Massachusetts (Mass) Eye and Ear conducted a retrospective, matched cohort study of 16,827 neuro-ophthalmic patients from one Boston, Massachusetts-based clinical practice to investigate the potential and suspected association between the use of semaglutide among diabetic patients with the risk of NAION
Bresolin N, Freddo L, Vergani L, Angelini C
NICE guidance does not support this combination in treatment algorithms, and the Specialist Pharmacy Service advises switching rather than adding when intensifying therapy
DripGym's team of experienced professionals carefully assesses each patient to recommend the most appropriate treatment plan, ensuring safety and optimal results
Tesofensine and semaglutide have both shown promise for weight loss in clinical trials, but they vary in their mechanisms of action and approved uses